Raymond James Financial Services Advisors’s Insight Molecular Diagnostics Inc. Common Stock IMDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-739
| Closed | -$3.4K | – | 3282 |
|
|
2023
Q2 | $3.4K | Hold |
739
| – | – | ﹤0.01% | 3218 |
|
|
2023
Q1 | $5.24K | Sell |
739
-100
| -12% | -$709 | ﹤0.01% | 3230 |
|
|
2022
Q4 | $5.38K | Hold |
839
| – | – | ﹤0.01% | 3183 |
|
|
2022
Q3 | $12K | Hold |
839
| – | – | ﹤0.01% | 3176 |
|
|
2022
Q2 | $15K | Hold |
839
| – | – | ﹤0.01% | 3151 |
|
|
2022
Q1 | $25K | Buy |
+839
| New | +$25K | ﹤0.01% | 3208 |
|
|
2021
Q4 | – | Sell |
-787
| Closed | -$56K | – | 3315 |
|
|
2021
Q3 | $56K | Buy |
+787
| New | +$56K | ﹤0.01% | 3163 |
|